Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Immunocore
company
Funding Round
Post-IPO Equity
Money Raised
$ 140M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| General Atlantic | - | - | - | Detail |
| Rock Springs Capital | - | - | - | Detail |
| RTW Investments | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jan 11, 2021 | Series C | $ 75M | BlackRock | Detail |
| Jul 16, 2015 | Series A | $ 320M | Eli Lilly,RTW Investments,etc. | Detail |
| Nov 5, 2012 | Grant | £ 2.40M | Biomedical Catalyst Fund | Detail |
| Jan 11, 2021 | Debt Financing | $ 100M | Oxford Finance LLC | Detail |
| Mar 2, 2020 | Series B | $ 130M | Bill & Melinda Gates Foundation,CCB International,etc. | Detail |
| Sep 18, 2017 | Series B | $ 40M | Bill & Melinda Gates Foundation | Detail |
| Feb 4, 2021 | IPO | $ 258.31M | Detail |
